Limitations of evidence base for prescribing aripiprazole in maintenance therapy of bipolar disorder
Tuesday, May 3, 2011 - 18:30
in Health & Medicine
The evidence base for the prescribing of aripiprazole in maintenance treatment of bipolar disorder is limited to a single trial, sponsored by the manufacturer of aripiprazole, according to a rigorous appraisal of the evidence for its use.